Literature DB >> 28406743

The "readers" of unacetylated p53 represent a new class of acidic domain proteins.

Donglai Wang1, Ning Kon1, Omid Tavana1, Wei Gu1.   

Abstract

Acetylation of non-histone proteins plays important roles in regulating protein functions but the mechanisms of action are poorly understood. Our recent study uncovered a previously unknown mechanism by which C-terminal domain (CTD) acetylation of p53 serves as a "switch" to determine the interaction between a unique group of acidic domain-containing proteins and p53, as well as revealed that acidic domains may act as a novel class of "readers" for unacetylated p53. However, the properties of acidic domain "readers" are not well elucidated yet. Here, we identified that the charge effect between acidic domain "readers" and the p53 CTD is necessary for their interaction. Both the length and the amino acid composition of a given acidic domain contributed to its ability to recognize the p53 CTD. Finally, we summarized the characteristic features of our identified acidic domains, which would distinguish this kind of "readers" from other types of acidic amino acid-containing domains.

Entities:  

Keywords:  C-terminal domain; SET; acetylation; acidic domain; p53

Mesh:

Substances:

Year:  2017        PMID: 28406743      PMCID: PMC5597292          DOI: 10.1080/19491034.2017.1313939

Source DB:  PubMed          Journal:  Nucleus        ISSN: 1949-1034            Impact factor:   4.197


  46 in total

Review 1.  Blinded by the Light: The Growing Complexity of p53.

Authors:  Karen H Vousden; Carol Prives
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

Review 2.  Acetylation of non-histone proteins modulates cellular signalling at multiple levels.

Authors:  Stephanie Spange; Tobias Wagner; Thorsten Heinzel; Oliver H Krämer
Journal:  Int J Biochem Cell Biol       Date:  2008-09-02       Impact factor: 5.085

Review 3.  The p53-mdm2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53?

Authors:  S M Picksley; D P Lane
Journal:  Bioessays       Date:  1993-10       Impact factor: 4.345

4.  Three functional classes of transcriptional activation domain.

Authors:  J Blau; H Xiao; S McCracken; P O'Hare; J Greenblatt; D Bentley
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

5.  Ferroptosis as a p53-mediated activity during tumour suppression.

Authors:  Le Jiang; Ning Kon; Tongyuan Li; Shang-Jui Wang; Tao Su; Hanina Hibshoosh; Richard Baer; Wei Gu
Journal:  Nature       Date:  2015-03-18       Impact factor: 49.962

6.  Negative control of p53 by Sir2alpha promotes cell survival under stress.

Authors:  J Luo; A Y Nikolaev; S Imai; D Chen; F Su; A Shiloh; L Guarente; W Gu
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

7.  Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation.

Authors:  X Chen; G Farmer; H Zhu; R Prywes; C Prives
Journal:  Genes Dev       Date:  1993-10       Impact factor: 11.361

8.  Human TAFII31 protein is a transcriptional coactivator of the p53 protein.

Authors:  H Lu; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

9.  Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein.

Authors:  R Truant; H Xiao; C J Ingles; J Greenblatt
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

10.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  7 in total

1.  FOXO4 interacts with p53 TAD and CRD and inhibits its binding to DNA.

Authors:  Raju Mandal; Klara Kohoutova; Olivia Petrvalska; Matej Horvath; Pavel Srb; Vaclav Veverka; Veronika Obsilova; Tomas Obsil
Journal:  Protein Sci       Date:  2022-05       Impact factor: 6.725

Review 2.  Deciphering the acetylation code of p53 in transcription regulation and tumor suppression.

Authors:  Zhangchuan Xia; Ning Kon; Alyssa P Gu; Omid Tavana; Wei Gu
Journal:  Oncogene       Date:  2022-04-29       Impact factor: 8.756

3.  Robust p53 Stabilization Is Dispensable for Its Activation and Tumor Suppressor Function.

Authors:  Ning Kon; Michael Churchill; Huan Li; Siddhartha Mukherjee; James J Manfredi; Wei Gu
Journal:  Cancer Res       Date:  2020-12-15       Impact factor: 13.312

4.  HDAC2 Regulates Site-Specific Acetylation of MDM2 and Its Ubiquitination Signaling in Tumor Suppression.

Authors:  Nikita Patel; Juehong Wang; Kumiko Shiozawa; Kevin B Jones; Yanfeng Zhang; Jeremy W Prokop; George G Davenport; Naoe T Nihira; Zhenyue Hao; Derek Wong; Laurel Brandsmeier; Sarah K Meadows; Arthur V Sampaio; Ryan Vander Werff; Makoto Endo; Mario R Capecchi; Kelly M McNagny; Tak W Mak; Torsten O Nielsen; T Michael Underhill; Richard M Myers; Tadashi Kondo; Le Su
Journal:  iScience       Date:  2019-02-15

Review 5.  Battle of the sexes: contrasting roles of testis-specific protein Y-encoded (TSPY) and TSPX in human oncogenesis.

Authors:  Yun-Fai Chris Lau; Yunmin Li; Tatsuo Kido
Journal:  Asian J Androl       Date:  2019 May-Jun       Impact factor: 3.285

Review 6.  Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53.

Authors:  Mayra A Marques; Guilherme C de Andrade; Jerson L Silva; Guilherme A P de Oliveira
Journal:  Front Mol Biosci       Date:  2022-08-25

7.  MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma.

Authors:  Saurabh Agarwal; Giorgio Milazzo; Kimal Rajapakshe; Ronald Bernardi; Zaowen Chen; Eveline Barbieri; Jan Koster; Giovanni Perini; Cristian Coarfa; Jason M Shohet
Journal:  Oncotarget       Date:  2018-04-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.